title: [Treatment of stage I pure seminoma of the testis, value of prophylactic radiotherapy].
abstract: Teleradiotherapy is the treatment of choice for stage I testicular pure seminoma. In this study of 130 patients, we compared the dose of 35 and 30 Gy given prophylactically. No statistically significant difference in survival was observed between the groups.
authors.affiliation: Service de radiothérapie, institut oncologique, Cracovie, Pologne.
authors.forename: M
authors.initials: M
authors.lastname: Reinfuss
authors.forename: J
authors.initials: J
authors.lastname: Skolyszewski
authors.forename: B
authors.initials: B
authors.lastname: Gliński
authors.forename: D
authors.initials: D
authors.lastname: Kociolek
authors.forename: T
authors.initials: T
authors.lastname: Kowalska
mesh_terms: D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009919:Orchiectomy; D011879:Radiotherapy Dosage; D018239:Seminoma / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D016019:Survival Analysis; D013736:Testicular Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery
vernacular_title: Traitement des séminomes purs du testicule stade I, intérêt de la radiothérapie prophylactique.